Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02642302
Other study ID # UNIVERSO-02
Secondary ID
Status Not yet recruiting
Phase N/A
First received December 5, 2015
Last updated December 25, 2015
Start date December 2015
Est. completion date April 2016

Study information

Verified date December 2015
Source Universidade Federal do Rio de Janeiro
Contact Sérgio E. Machado, PhD
Phone 55 21 991567006
Email secm80@gmail.com
Is FDA regulated No
Health authority Brazil: National Committee of Ethics in Research
Study type Interventional

Clinical Trial Summary

Based on studies of high intensity interval training (HIIT) in the literature, higher gains in VO2max and performance are obtained in short periods of training time. However, different designs training configurations, for example, changing the time interval, could influence such gains on VO2max and aerobic performance. The aim of the study was to observe the possible influences of diferetes types of rest intervals in high intensity interval exercise protocol on VO2max, and the aerobic and anaerobic performances in 12 weeks of training.


Description:

12-week experiment will be conducted, with a total of 30 high intensity interval training (HIIT) sessions in cycle ergometer. Both the first and the last week will serve to stabilize the basic values and also repeated after training. So, every other day will be held: 1) risk stratification for coronary artery disease, anthropometric measurements, cardiopulmonary test maximum effort; 2) stabilization of cardiopulmonary test values, determining the aerobic dependent variables: VO2max, peak power - PP, occurrence of power VO2max - PVO2Máx, maximum heart rate - HRMax, as well as familiarization with the HIIT protocol; 3) anaerobic performance test of 30 seconds determining the anaerobic dependent variables: peak lactate - LA, anaerobic power peak - PP, average power - PM. After the dependent variables have established, the subjects will be randomly distributed among three groups: two experimental and one control, and subjected to 30 sessions of HIIT (all out)with 30 seconds of stimulation in cycle ergometer, differentiated only by the recovery time (60 seconds and 120 seconds). The control group had only one continuous aerobic exercise (50-55% VO2max) with an average time similar to other training.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 36
Est. completion date April 2016
Est. primary completion date February 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- practitioners of aerobic activities for 6 mounths

- negative prognosis for cardiovascular or metabolic disease

Exclusion Criteria:

- muscle injuries

- use ergogenic resources

- cardiovascular disease

- other limitations

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)


Related Conditions & MeSH terms


Intervention

Behavioral:
HIIT With 60 sec Rest
30 sessions of High intensity interval training (all out) with 30 seconds of stimulous with 60 seconds rest on VO2Max and aerobic/ anaerobic performance
HIIT With120 sec Rest
30 sessions of High intensity interval training (all out) with 30 seconds of stimulous with 120 seconds rest on VO2Max and aerobic/ anaerobic performance
Control
Continuous exercise at 50-55% VO2Max with similar total work of interval training

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal do Rio de Janeiro

Outcome

Type Measure Description Time frame Safety issue
Primary Oxygen Intake (VO2Max) Against of Differents Rest Time of High Intensity Interval Training Change From Baseline VO2Max after 12 Weeks of High Intensity Interval Training No
Secondary Aerobic and Anaerobic Power Peak Performance Against of Differents Rest Time of High Intensity Change From Baseline in Aerobic and Anaerobic Performance after 12 Weeks of High Intensity Interval Training No
Secondary Lactate Concentration Change From Baseline in Lactate Concentration after 12 Weeks of High Intensity Interval Training No
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1